Advisors Asset Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 5,608 shares of REGN stock, worth $3.94 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,608

Previous 6,633 15.45%

Holding current value

$3.94 Million

Previous $6.97 Million 15.44%

% of portfolio

0.11%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $1.05 Million - $1.23 Million	-1,025 Reduced 15.45%	5,608 $5.9 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $869,068 - $1.05 Million	-984 Reduced 12.92%	6,633 $6.97 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $683,336 - $751,965	-757 Reduced 9.04%	7,617 $7.33 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $496,115 - $564,288	-640 Reduced 7.1%	8,374 $7.35 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $471,820 - $559,655	-674 Reduced 6.96%	9,014 $6.48 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $913,217 - $1.11 Million	1,342 Added 16.08%	9,688 $7.96 Million
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $82,651 - $104,302	-144 Reduced 1.79%	7,888 $5.43 Million
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $377,813 - $509,060	-689 Reduced 7.9%	8,032 $4.75 Million
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $1.24 Million - $1.46 Million	-2,091 Reduced 19.34%	8,721 $6.09 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $1.44 Million - $1.77 Million	-2,642 Reduced 19.64%	10,812 $6.83 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $373,119 - $442,624	-650 Reduced 4.61%	13,454 $8.14 Million
Q2 2021 Jul 30, 2021	SELL	$472.8 - $558.54 $1.37 Million - $1.61 Million	-2,889 Reduced 17.0%	14,104 $7.88 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $2.11 Million - $2.59 Million	-4,726 Reduced 21.76%	16,993 $8.04 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $256,847 - $326,485	-537 Reduced 2.41%	21,719 $10.5 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $606,306 - $732,587	-1,113 Reduced 4.76%	22,256 $12.5 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $791,285 - $1.03 Million	1,604 Added 7.37%	23,369 $14.6 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $328,784 - $483,552	978 Added 4.7%	21,765 $10.6 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $903,806 - $1.24 Million	3,297 Added 18.85%	20,787 $7.81 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1.07 Million - $1.25 Million	3,915 Added 28.84%	17,490 $4.85 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.15 Million - $1.6 Million	3,848 Added 39.56%	13,575 $4.25 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $922,014 - $1.09 Million	2,478 Added 34.18%	9,727 $3.99 Million
Q4 2018 Jan 31, 2019	BUY	$335.82 - $403.04 $1.13 Million - $1.36 Million	3,378 Added 87.26%	7,249 $2.71 Million
Q3 2018 Nov 15, 2018	SELL	$351.14 - $408.51 $384,498 - $447,318	-1,095 Reduced 22.05%	3,871 $1.56 Million
Q2 2018 Aug 15, 2018	SELL	$284.6 - $344.99 $567,777 - $688,255	-1,995 Reduced 28.66%	4,966 $1.71 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $26,528 - $33,077	-84 Reduced 1.19%	6,961 $2.23 Million
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $71,008 - $93,050	198 Added 2.89%	7,045 $2.65 Million
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $2.95 Million - $3.45 Million	6,847	6,847 $3.06 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History